Tharimmune, Inc. (NASDAQ:THAR – Get Free Report) saw a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 26,000 shares, a growth of 68.8% from the May 31st total of 15,400 shares. Based on an average daily volume of 43,100 shares, the days-to-cover ratio is currently 0.6 days. Currently, 3.4% of the company’s shares are sold short.
Tharimmune Trading Up 9.3 %
THAR traded up $0.30 during trading on Friday, hitting $3.53. 66,986 shares of the stock were exchanged, compared to its average volume of 90,199. The firm has a 50 day simple moving average of $4.69 and a 200 day simple moving average of $5.84. Tharimmune has a 1 year low of $2.75 and a 1 year high of $163.09.
Tharimmune (NASDAQ:THAR – Get Free Report) last released its quarterly earnings data on Thursday, May 9th. The company reported ($2.85) EPS for the quarter.
About Tharimmune
Tharimmune, Inc, a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1).
Further Reading
- Five stocks we like better than Tharimmune
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- How Technical Indicators Can Help You Find Oversold Stocks
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for Tharimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tharimmune and related companies with MarketBeat.com's FREE daily email newsletter.